Effect of MINODRONATE (cas 127657-42-5) on the speed of sound of the calcaneus in postmenopausal women with an increased risk of fractures: A clinical practice-based observational study
-
Add time:08/11/2019 Source:sciencedirect.com
BackgroundWe previously reported that alendronate and risedronate reduce the urinary levels of cross-linked N-terminal telopeptides of type I collagen (NTX) by 44.9% and 34.7%, respectively, at 3 months after the start of treatment, and increase the speed of sound (SOS) of the calcaneus by 0.6% and 0.65%, respectively, at 12 months after the start of treatment in postmenopausal women with osteoporosis. The aim of the present clinical practice-based observational study was to examine the effect of treatment with MINODRONATE (cas 127657-42-5) for 12 months on the SOS of the calcaneus and on bone turnover markers in postmenopausal women with an increased risk of fractures.
We also recommend Trading Suppliers and Manufacturers of MINODRONATE (cas 127657-42-5). Pls Click Website Link as below: cas 127657-42-5 suppliers
Prev:Monthly MINODRONATE (cas 127657-42-5) inhibits bone resorption to a greater extent than does monthly risedronate
Next:Combined treatment with MINODRONATE (cas 127657-42-5) and vitamin C increases bone mineral density and strength in vitamin C-deficient rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- MINODRONATE (cas 127657-42-5), a Newly Developed Nitrogen-Containing Bisphosphonate, Suppresses Melanoma Growth and Improves Survival in Nude Mice by Blocking Vascular Endothelial Growth Factor Signaling08/17/2019
- MINODRONATE (cas 127657-42-5), a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy08/16/2019
- A double-blinded head-to-head trial of MINODRONATE (cas 127657-42-5) and alendronate in women with postmenopausal osteoporosis08/15/2019
- Comparison of effectiveness and safety of ibandronate and MINODRONATE (cas 127657-42-5) combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study08/14/2019
- Effects of MINODRONATE (cas 127657-42-5) on cortical bone response to mechanical loading in rats08/13/2019
- Combined treatment with MINODRONATE (cas 127657-42-5) and vitamin C increases bone mineral density and strength in vitamin C-deficient rats08/12/2019
- Monthly MINODRONATE (cas 127657-42-5) inhibits bone resorption to a greater extent than does monthly risedronate08/10/2019
- Initiation of Monthly MINODRONATE (cas 127657-42-5) Therapy at an Early Stage After Hip Fracture08/09/2019
- Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly MINODRONATE (cas 127657-42-5) therapy in postmenopausal women with osteoporosis08/08/2019
